CC2019: Ten Hot Topics In Surgical Oncology (C)

This session has been identified and designated as Credit to Meet ACS Accreditation/Verification Requirements for Cancer. Learn more about ACS Accreditation/Verification Requirements.

Session Description

Ten of the most current and controversial issues in surgical oncology are described in this session. It will include short, focused discussions on the evolving indications for surgery in melanoma patients in the era of effective immune therapies, the optimal use of neoadjuvant chemotherapy for pancreatic cancer, the appropriate management of complications of breast surgery, and the use of ablation techniques in breast surgery. This program will also address updates in the management of gastrointestinal (GI) stromal tumors, small pancreatic neuroendocrine tumors, and metastatic colorectal and neuroendocrine tumors to the liver. Finally, the program will address the state of the evidence for minimally invasive surgery for rectal cancer and what surgeons should know about “watch and wait” after neoadjuvant therapy of rectal tumors.

Moderator: Douglas S. Tyler, MD, FACS, Galveston, TX

Co-Moderator: James R. Howe, MD, FACS, Iowa City, IA

Presentations

New Approaches to Managing Melanoma
Douglas S. Tyler, MD, FACS, Galveston, TX

Neoadjuvant Approaches to Resectable Pancreatic Cancer
Douglas S. Tyler, MD, FACS, Galveston, TX

Small Pancreatic Neuroendocrine Tumors: Resect or Observe?
James R. Howe, MD, FACS, Iowa City, IA

Options for Treating Metastatic Neuroendocrine Tumors
James R. Howe, MD, FACS, Iowa City, IA

The Role of the Surgeon in Managing Gastrointestinal Stromal Tumors (GIST)
Jason K. Sicklick, MD, FACS, La Jolla, CA

Management of Colorectal Liver Metastases to the Liver
Jason K. Sicklick, MD, FACS, La Jolla, CA

Watch and Wait for Rectal Cancer
Matthew F. Kalady, MD, FACS, Cleveland, OH

Technical Advances in Managing Rectal Cancer
Matthew F. Kalady, MD, FACS, Cleveland, OH

Managing Pain and Lymphedema after Breast Cancer Treatment
V. Suzanne Klimberg, MD, PhD, FACS, Galveston, TX

Ablation of Breast Tumors: Is It Ready for Prime Time?
V. Suzanne Klimberg, MD, PhD, FACS, Galveston, TX

Sponsored by the Division of Education and the Commission on Cancer

Target Audience

  • Practicing surgeons
  • Residents

Learning Objectives

  • Apply new knowledge and ideas to improve their surgical practice
  • Adapt concepts and quality measures in support of research advancements
  • Enhance the quality of patient care

Contact

For questions about the course, please contact elearning@facs.org.

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Self Assessment Credit
  • 1.50 Certificate of Completion
Course opens: 
11/15/2019
Course expires: 
01/05/2021

Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest. For additional information, please visit the ACCME website.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during a activity, please report it on the evaluation.

(Download the full list of disclosures).

Faculty and Disclosures

Douglas S. Tyler, MD, FACS - Array Pharmaseuticals: Honorarium: Advisory Board; Up to Date: Royalties: Writer; Castle Bioscience: Honorarium: Advisory Board
James R. Howe MD, FACS - Nothing to Disclose
Jason K. Sicklick, MD, FACS - Amgen: Research Funding: PI; Novartis Pharmaceuticals: Research Funding: PI; CARsgen Therapeutics Corporation: Honoraria: Consultant; Foundation Medicine, Inc: Research Funding: PI; Grand Rounds: Honoraria: Consultant; Loxo Oncology: Honoraria: Consultant
Matthew F. Kalady MD, FACS - Nothing to Disclose
V. Suzanne Klimberg MD, PhD, FACS - Nothing to Disclose

Program Committee and Disclosures

CHAIR: Henri R. Ford, MD, MHA, FACS, FAAP, FRCSEng(Hon), Miami, FL - Nothing to Disclosure
VICE-CHAIR: David T. Cooke, MD, FACS, Sacramento, CA - Nothing to Disclosure

Members

David C. Borgstrom, MD, FACS, Morgantown, WV - Nothing to Disclosure
Daniel L. Dent, MD, FACS, San Antonio, TX - Nothing to Disclosure
Roger R. Dmochowski, MD, FACS, Nashville, TN - Allergen: Honoraria: Consultant
Cynthia D. Downard, MD, FACS, Louisville, KY - Nothing to Disclosure
Audra A. Duncan, MD, FACS, London, ON - Nothing to Disclosure
Mariam F. Eskander, MD, Boston, MA - Nothing to Disclosure
Paula Ferrada, MD, FACS, Richmond, VA - Nothing to Disclosure
Neil H. Hyman, MD, FACS, Chicago, IL - Nothing to Disclosure
Martin S. Karpeh, Jr., MD, FACS, New York, NY - Nothing to Disclosure
Dennis H. Kraus, MD, FACS, New York, NY - Nothing to Disclosure
Kenneth W. Sharp, MD, FACS, Nashville, TN - Nothing to Disclosure

Ex-Officios

Daniel M. Herron, MD, FACS, FASBMS, New York, NY - Nothing to Disclosure
Edith Tzeng, MD, FACS, Pittsburgh, PA - Nothing to Disclosure

Consultants

Barbara Lee Bass, MD, FACS, FRCSEng(Hon), FRCSI(Hon), FCOSECSA(Hon), Houston, TX - Nothing to Disclosure
Quan-Yang Duh, MD, FACS, San Francisco, CA - Nothing to Disclosure
B. J. Hancock, MD, FACS, FRCSC, Winnipeg, MB - Nothing to Disclosure
Ronald V. Maier, MD, FACS, FRCSEd(Hon), Seattle, WA - Nothing to Disclosure

Continuing Medical Education Credit Information

Accreditation

The American College of Surgeons is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™

The American College of Surgeons designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Of the AMA PRA Category 1 Credits™ listed above, a maximum of 1.5 credits meets the requirements for Self-Assessment.

American College of Surgeons and ACGME Logos

Note: Residents will receive a Certificate of Completion.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Self Assessment Credit
  • 1.50 Certificate of Completion

Accreditation Period

Course opens: 
11/15/2019
Course expires: 
01/05/2021
Please login or register to take this course.

This course is available as part of the Clinical Congress 2019 Webcast Packages